D
Dauh-Rurng Wu
Researcher at Bristol-Myers Squibb
Publications - 65
Citations - 958
Dauh-Rurng Wu is an academic researcher from Bristol-Myers Squibb. The author has contributed to research in topics: Supercritical fluid chromatography & Chemistry. The author has an hindex of 14, co-authored 56 publications receiving 700 citations.
Papers
More filters
Journal ArticleDOI
Enantioselective chromatography in drug discovery.
TL;DR: Different enantioselective chromatography techniques are reviewed here, with particular emphasis on the most widespread high performance liquid Chromatography (HPLC) and the rapidly emerging supercritical fluid chromatography (SFC) techniques.
Journal ArticleDOI
Discovery of 6-Fluoro-5-(R)-(3-(S)-(8-fluoro-1-methyl-2,4-dioxo-1,2-dihydroquinazolin-3(4H)-yl)-2-methylphenyl)-2-(S)-(2-hydroxypropan-2-yl)-2,3,4,9-tetrahydro-1H-carbazole-8-carboxamide (BMS-986142): A Reversible Inhibitor of Bruton's Tyrosine Kinase (BTK) Conformationally Constrained by Two Locked Atropisomers.
Scott H. Watterson,George V. De Lucca,Qing Shi,Charles M. Langevine,Qingjie Liu,Douglas G. Batt,Myra Beaudoin Bertrand,Hua Gong,Jun Dai,Shiuhang Yip,Peng Li,Dawn Sun,Dauh-Rurng Wu,Chunlei Wang,Yingru Zhang,Sarah C. Traeger,Mark A. Pattoli,Stacey Skala,Lihong Cheng,Mary T. Obermeier,Rodney Vickery,Lorell Discenza,Celia D’Arienzo,Yifan Zhang,Elizabeth M. Heimrich,Kathleen M. Gillooly,Tracy L. Taylor,Claudine Pulicicchio,Kim W. McIntyre,Michael Galella,Andy J. Tebben,Jodi K. Muckelbauer,Chiehying Chang,Richard Rampulla,Arvind Mathur,Luisa Salter-Cid,Joel C. Barrish,Percy H. Carter,Aberra Fura,James R. Burke,Joseph A. Tino +40 more
TL;DR: The structure-activity relationships (SAR) leading to a novel series of highly potent and selective carbazole and tetrahydrocarbazole based, reversible inhibitors of BTK are detailed, resulting in enhanced potency and selectivity as well as a reduction in safety liabilities.
Journal ArticleDOI
Discovery of Clinical Candidate BMS-906024: A Potent Pan-Notch Inhibitor for the Treatment of Leukemia and Solid Tumors.
Ashvinikumar V. Gavai,Claude A. Quesnelle,Derek J. Norris,Wen-Ching Han,Patrice Gill,Weifang Shan,Aaron Balog,Ke Chen,Andrew J. Tebben,Richard Rampulla,Dauh-Rurng Wu,Yingru Zhang,Arvind Mathur,Ronald E. White,Anne Rose,Haiqing Wang,Zheng Yang,Asoka Ranasinghe,Celia D’Arienzo,Victor R. Guarino,Lan Xiao,Ching Su,Gerry Everlof,Vinod Arora,Ding Ren Shen,Mary Ellen Cvijic,Krista Menard,Mei-Li Wen,Jere E. Meredith,George L. Trainor,Louis J. Lombardo,Richard E. Olson,Phil S. Baran,John T. Hunt,Gregory D. Vite,Bruce S. Fischer,Richard A. Westhouse,Francis Y. Lee +37 more
TL;DR: Structure-activity relationships in a series of (2-oxo-1,4-benzodiazepin-3-yl)-succinamides identified highly potent inhibitors of γ-secretase mediated signaling of Notch1/2/3/4 receptors selected as a candidate for clinical evaluation.
Journal ArticleDOI
Structure-based Discovery of Phenyl (3-Phenylpyrrolidin-3-yl)sulfones as Selective, Orally Active RORγt Inverse Agonists.
Jingwu Duan,Zhonghui Lu,Bin Jiang,Sylwia Stachura,Carolyn A. Weigelt,John S. Sack,Javed Khan,Max Ruzanov,Michael Galella,Dauh-Rurng Wu,Melissa Yarde,Ding-Ren Shen,David J. Shuster,Virna Borowski,Jenny Xie,Lisa Zhang,Sridhar Vanteru,Arun Kumar Gupta,Arvind Mathur,Qihong Zhao,William R. Foster,Luisa Salter-Cid,Percy H. Carter,T. G. Murali Dhar +23 more
TL;DR: A new phenyl (3-phenylpyrrolidin-3-yl)sulfone series of RORγt inverse agonists was discovered utilizing the binding conformation of previously reported bicyclic sulfonamide 1 to achieve high selectivity against PXR, LXRα, and LXRβ.
Journal ArticleDOI
Identification of bicyclic hexafluoroisopropyl alcohol sulfonamides as retinoic acid receptor-related orphan receptor gamma (RORγ/RORc) inverse agonists. Employing structure-based drug design to improve pregnane X receptor (PXR) selectivity
Hua Gong,David S. Weinstein,Zhonghui Lu,Jingwu Duan,Sylwia Stachura,Lauren Haque,Ananta Karmakar,Hemalatha Hemagiri,Dhanya Kumar Raut,Arun Kumar Gupta,Javed Khan,Dan Camac,John S. Sack,Andrew T. Pudzianowski,Dauh-Rurng Wu,Melissa Yarde,Ding-Ren Shen,Virna Borowski,Jenny Xie,Huadong Sun,Celia D’Arienzo,Marta Dabros,Michael Galella,Faye Wang,Carolyn A. Weigelt,Qihong Zhao,William R. Foster,John E. Somerville,Luisa Salter-Cid,Joel C. Barrish,Percy H. Carter,T. G. Murali Dhar +31 more
TL;DR: The optimization of a high throughput screening hit to yield benzothiazine and tetrahydroquinoline sulfonamides as potent RORγt inverse agonists showed potent activity against pregnane X receptor (PXR) and modest activity against liver X receptor α (XRα).